Atea Pharmaceuticals (NASDAQ:AVIR – Get Free Report) announced its quarterly earnings data on Wednesday. The company reported ($0.41) EPS for the quarter, beating the consensus estimate of ($0.56) by $0.15, FiscalAI reports. Atea Pharmaceuticals Stock Performance Shares of NASDAQ:AVIR traded up $0.01 during midday trading on Wednesday, reaching $5.06. 292,168 shares of the company’s stock [...]
Atea Pharmaceuticals (NASDAQ:AVIR) Announces Quarterly Earnings Results, Beats Expectations By $0.15 EPS
